All patients with the BRAF mutation were diagnosed with PTC. The study concluded that patients with thyroid nodules <1.5 cm, exhibiting two or more suspicious US features, a BRAF mutation, or multiple AUS results on repeat FNAs, warranted close monitoring or diagnostic surgery. This evidence concerns the gene BRAF and thyroid nodule.